Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. - Wikidata - awgldk - TriplyDB

Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.

Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.

http://www.wikidata.org/entity/Q30485147

about

Targeted therapy for HM1.24 (CD317) on multiple myeloma cells Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cells Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell.Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition.Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation.Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myeloma.Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional study.CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax®23 Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.Characterization of human FCRL4-positive B cells.Trial watch: Prognostic and predictive value of the immune infiltrate in cancer Differential effects of lenalidomide during plasma cell differentiation Follicular B cells in thyroids of mice with spontaneous autoimmune thyroiditis contribute to disease pathogenesis and are targets of anti-CD20 antibody therapy.PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood.The human counterpart of mouse B-1 cells.Involvement of Semaphorin (Sema4D) in T-Dependent Activation of B Cells.DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D.Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.Flow cytometry assessment of in vitro generated CD138+ human plasma cells.Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B Cells.Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc-/- mice.Plasma cell alloantigen ENPP1 is expressed by a subset of human B cells with potential regulatory functions.TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells.Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma.IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression.Hypoxia favors the generation of human plasma cells.IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.

P2860

Q27026161-0A95238C-1D69-4DBF-B315-A0B7EF1F8EF3 Q28487347-AA54506A-483E-4B0F-8AE0-519AE25505B4 Q28552355-0B155E30-E7B7-4179-86C7-CEED2DF51E0C Q30886634-B5EC9BD5-0B04-4866-B471-F4F295CA8473 Q33404838-892F3A62-2B51-4F96-94A8-6020A500F597 Q33741100-71805DB8-FA26-4296-8815-67681897A868 Q33762211-0409DA56-B50B-4E6C-B119-337F323267B1 Q33777284-402AD9E6-039E-4DCA-B9D1-8B6AA7C0CC6C Q33842381-EE7F3B4E-0BCB-47A9-B213-794B3BC63A56 Q34052050-AD8B74AF-EAEC-4F95-AC04-42F996A02219 Q34364560-1ABB9DDF-C0CF-4F78-9220-7B6F9F0F7634 Q35512854-FDA71ECB-35AB-4790-8E23-382A38274299 Q35560706-B92F8323-8133-490E-A2E6-A4C5E7A0CDEE Q35974921-28C38EB3-288B-4757-8596-21D4BE495F29 Q36376043-CB0057A8-BA0E-4F97-9041-8AE24B5EA3B4 Q36411427-EBC45E26-C174-44D7-AF72-665A79FB5F42 Q36456483-2731081C-EF4E-4D0B-B10A-554A9CC31523 Q37317494-E066BDB5-7849-4F9F-8833-A1691E278308 Q37512037-23D0816F-135A-45E5-BA09-18E1ECF2BE56 Q37690298-566581E4-0637-407D-A157-05FB641056D1 Q37701444-B9C8894B-AA53-4CCC-84FA-C6355FDA4ACA Q38491162-1F377A26-983A-42FC-9189-8A5497510B02 Q38602592-ED368261-2D81-4B87-9976-408385D86AEE Q38707040-05FA8236-FFC0-4E93-B2DB-38C9BD94B13A Q38724993-B7A3D8E1-5119-43CC-9682-033711852B04 Q38768232-35EB46E0-7537-40FC-94D9-2A8F78CE577D Q38910971-2CBCF2E2-447D-4E26-B0D2-6D32E3CAA2FA Q39009554-73B7306B-0434-4A68-A623-612F32405F3A Q39143583-6E11BE79-7BDA-4AEC-AB89-3EA4A4839C98 Q39319246-ACF15C4C-96E9-4E41-A580-A5CDAF609F96 Q40258774-C054CFAA-C140-4F87-A7D0-319406F58431 Q40560385-681A618E-EDF9-429A-84A0-0235C22AA71F Q40735115-F499A461-0683-40D0-AC9C-9B8DA2685FFF Q41819292-6C3BDCD2-39CB-4DB5-BEF5-BC1FF0AB9A03 Q42127664-47DF882D-6BC5-4FC6-9039-C387DFAE047A Q42459032-50144529-AC73-4A1C-91E2-AF8A56E19908 Q42762683-CBEF2380-D339-4CBF-953F-28CD2F106349 Q47108872-39B76125-F0C7-4B2A-BA45-DCA33417264E Q48207902-594BDDF8-5FC3-45EB-BFC7-28247B9AC6FB Q50861647-FB85BDF0-BAC5-4155-979E-6FE578E95B56

P2860

Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.

http://www.wikidata.org/entity/Q30485147

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Characterization of a transiti ...... o plasma cell differentiation.

@ast

Characterization of a transiti ...... o plasma cell differentiation.

@en

type

label

Characterization of a transiti ...... o plasma cell differentiation.

@ast

Characterization of a transiti ...... o plasma cell differentiation.

@en

prefLabel

Characterization of a transiti ...... o plasma cell differentiation.

@ast

Characterization of a transiti ...... o plasma cell differentiation.

@en

P1433

Q30485147-9E1D1610-136E-45DB-82E3-F9AF942E5A98

P1476

Q30485147-07176426-1293-4AB7-B93F-696E599A99E3

P2093

Q30485147-06074257-D2BB-4315-93B8-C7A5AD0A3ED8

Q30485147-3D5C4882-18DA-4E9D-AB05-32B7984CD464

Q30485147-6E4B71E2-0386-4032-8582-573DEE1E8663

Q30485147-835B20C2-A473-4E28-8785-8D828670496D

Q30485147-89176A44-B08D-46AC-B039-8083CF6232A6

Q30485147-922F7E55-9E6D-4967-830E-D3C35B4CAC65

Q30485147-9839F286-D07C-4785-AB69-C46BA8829DE3

Q30485147-9F2B9A37-0204-4CBB-8C81-BFA1F3E16F74

Q30485147-B8349A76-0B36-48FC-A96A-A5142249C203

Q30485147-C45E7AAE-579D-4395-9F56-1A5371C7760E

P304

Q30485147-562CC088-8A25-43FB-983E-4FE1F517A192

P31

Q30485147-20797EE8-F328-42A8-AD18-FE1D12A31B07

P356

Q30485147-73E82116-6883-43AC-81A9-3D5FB06D5801

P407

Q30485147-147FCF8C-BFC8-49FA-A534-3112FD9F8A8D

P433

Q30485147-60146F7C-C1C0-4E13-AB9E-D7A15A10475A

P478

Q30485147-35CECB9C-C165-4227-9C23-F38682A77F2D

P50

Q30485147-404389BB-84A1-41C3-8CAB-56C4FDC7BEC2

Q30485147-6DD122A3-54D6-4550-BD87-960871214351

Q30485147-B12305C6-B7EE-420C-B29C-EC6897879975

Q30485147-CD8A6F3A-6791-49FE-939B-05D5481426F4

P577

Q30485147-A88B1086-22FA-4301-BBAF-0F9A2993A289

P5875

Q30485147-C36E61D0-A6F4-478D-A1E9-C346FAA40E49

P698

Q30485147-94714128-3B3A-46B9-B493-55AA1DBE249F

P356

JIMMUNOL.1101230

P1433

Journal of Immunology

P1476

Characterization of a transiti ...... o plasma cell differentiation.

@en

P2093

Alboukadel Kassambara

http://www.w3.org/2001/XMLSchema#string

Anouk Caraux

http://www.w3.org/2001/XMLSchema#string

Bernard Klein

http://www.w3.org/2001/XMLSchema#string

Frédéric Mourcin

http://www.w3.org/2001/XMLSchema#string

Geneviève Fiol

http://www.w3.org/2001/XMLSchema#string

Gersende Caron

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Vendrell

http://www.w3.org/2001/XMLSchema#string

Karin Tarte

http://www.w3.org/2001/XMLSchema#string

Karine Bolloré

http://www.w3.org/2001/XMLSchema#string

Michel Jourdan

http://www.w3.org/2001/XMLSchema#string

P304

3931-3941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1101230

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

187

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Duperray

P577

2011-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51643539

http://www.w3.org/2001/XMLSchema#string

P698

21918187

http://www.w3.org/2001/XMLSchema#string